Bryn Mawr Trust CO Biodesix Inc Transaction History
Bryn Mawr Trust CO
- $5.25 Billion
- Q1 2025
A detailed history of Bryn Mawr Trust CO transactions in Biodesix Inc stock. As of the latest transaction made, Bryn Mawr Trust CO holds 6,095,034 shares of BDSX stock, worth $1.83 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
6,095,034
Previous 6,095,034
-0.0%
Holding current value
$1.83 Million
Previous $9.14 Million
58.01%
% of portfolio
0.07%
Previous 0.17%
Shares
1 transactions
Others Institutions Holding BDSX
# of Institutions
64Shares Held
51.1MCall Options Held
65.5KPut Options Held
500-
Telemark Asset Management, LLC Boston, MA8.28MShares$2.48 Million0.75% of portfolio
-
Birchview Capital, LP Burlington, VT5.74MShares$1.72 Million3.25% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4.27MShares$1.28 Million1.45% of portfolio
-
Silverarc Capital Management, LLC4.1MShares$1.23 Million0.63% of portfolio
-
Monashee Investment Management LLC Boston, MA4.05MShares$1.22 Million0.35% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $12M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...